vs

Side-by-side financial comparison of CABOT CORP (CBT) and Virtu Financial, Inc. (VIRT). Click either name above to swap in a different company.

Virtu Financial, Inc. is the larger business by last-quarter revenue ($1.1B vs $849.0M, roughly 1.3× CABOT CORP). Virtu Financial, Inc. runs the higher net margin — 31.6% vs 8.6%, a 23.0% gap on every dollar of revenue. On growth, Virtu Financial, Inc. posted the faster year-over-year revenue change (30.7% vs -11.1%). Over the past eight quarters, Virtu Financial, Inc.'s revenue compounded faster (25.7% CAGR vs -8.7%).

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.

CBT vs VIRT — Head-to-Head

Bigger by revenue
VIRT
VIRT
1.3× larger
VIRT
$1.1B
$849.0M
CBT
Growing faster (revenue YoY)
VIRT
VIRT
+41.8% gap
VIRT
30.7%
-11.1%
CBT
Higher net margin
VIRT
VIRT
23.0% more per $
VIRT
31.6%
8.6%
CBT
Faster 2-yr revenue CAGR
VIRT
VIRT
Annualised
VIRT
25.7%
-8.7%
CBT

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CBT
CBT
VIRT
VIRT
Revenue
$849.0M
$1.1B
Net Profit
$73.0M
$346.6M
Gross Margin
24.9%
Operating Margin
15.2%
37.4%
Net Margin
8.6%
31.6%
Revenue YoY
-11.1%
30.7%
Net Profit YoY
-21.5%
82.8%
EPS (diluted)
$1.37
$1.99

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBT
CBT
VIRT
VIRT
Q1 26
$1.1B
Q4 25
$849.0M
$969.9M
Q3 25
$899.0M
$824.8M
Q2 25
$923.0M
$999.6M
Q1 25
$936.0M
$837.9M
Q4 24
$955.0M
$834.3M
Q3 24
$1.0B
$706.8M
Q2 24
$1.0B
$693.0M
Net Profit
CBT
CBT
VIRT
VIRT
Q1 26
$346.6M
Q4 25
$73.0M
$139.9M
Q3 25
$43.0M
$77.6M
Q2 25
$101.0M
$151.2M
Q1 25
$94.0M
$99.7M
Q4 24
$93.0M
$94.1M
Q3 24
$137.0M
$60.0M
Q2 24
$109.0M
$66.6M
Gross Margin
CBT
CBT
VIRT
VIRT
Q1 26
Q4 25
24.9%
Q3 25
24.5%
Q2 25
26.4%
Q1 25
25.7%
Q4 24
24.6%
Q3 24
24.0%
Q2 24
25.2%
Operating Margin
CBT
CBT
VIRT
VIRT
Q1 26
37.4%
Q4 25
15.2%
35.4%
Q3 25
15.2%
21.8%
Q2 25
18.1%
34.7%
Q1 25
17.3%
26.7%
Q4 24
16.2%
24.3%
Q3 24
15.0%
20.8%
Q2 24
16.9%
22.4%
Net Margin
CBT
CBT
VIRT
VIRT
Q1 26
31.6%
Q4 25
8.6%
14.4%
Q3 25
4.8%
9.4%
Q2 25
10.9%
15.1%
Q1 25
10.0%
11.9%
Q4 24
9.7%
11.3%
Q3 24
13.7%
8.5%
Q2 24
10.7%
9.6%
EPS (diluted)
CBT
CBT
VIRT
VIRT
Q1 26
$1.99
Q4 25
$1.37
$1.54
Q3 25
$0.80
$0.86
Q2 25
$1.86
$1.65
Q1 25
$1.69
$1.08
Q4 24
$1.67
$1.03
Q3 24
$2.41
$0.64
Q2 24
$1.94
$0.71

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBT
CBT
VIRT
VIRT
Cash + ST InvestmentsLiquidity on hand
$230.0M
$973.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.6B
$2.2B
Total Assets
$3.8B
$25.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBT
CBT
VIRT
VIRT
Q1 26
$973.2M
Q4 25
$230.0M
$1.1B
Q3 25
$258.0M
$707.9M
Q2 25
$239.0M
$752.1M
Q1 25
$213.0M
$723.6M
Q4 24
$183.0M
$872.5M
Q3 24
$223.0M
$701.4M
Q2 24
$197.0M
$684.8M
Total Debt
CBT
CBT
VIRT
VIRT
Q1 26
Q4 25
$2.0B
Q3 25
$1.1B
$2.0B
Q2 25
$1.7B
Q1 25
$1.7B
Q4 24
$1.7B
Q3 24
$1.1B
$1.7B
Q2 24
$1.7B
Stockholders' Equity
CBT
CBT
VIRT
VIRT
Q1 26
$2.2B
Q4 25
$1.6B
$1.6B
Q3 25
$1.6B
$1.5B
Q2 25
$1.5B
$1.4B
Q1 25
$1.4B
$1.3B
Q4 24
$1.4B
$1.3B
Q3 24
$1.4B
$1.2B
Q2 24
$1.3B
$1.2B
Total Assets
CBT
CBT
VIRT
VIRT
Q1 26
$25.1B
Q4 25
$3.8B
$20.2B
Q3 25
$3.8B
$21.3B
Q2 25
$3.8B
$19.3B
Q1 25
$3.8B
$17.5B
Q4 24
$3.6B
$15.4B
Q3 24
$3.7B
$14.4B
Q2 24
$3.6B
$13.9B
Debt / Equity
CBT
CBT
VIRT
VIRT
Q1 26
Q4 25
1.29×
Q3 25
0.70×
1.40×
Q2 25
1.24×
Q1 25
1.33×
Q4 24
1.39×
Q3 24
0.75×
1.41×
Q2 24
1.41×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBT
CBT
VIRT
VIRT
Operating Cash FlowLast quarter
$126.0M
Free Cash FlowOCF − Capex
$57.0M
FCF MarginFCF / Revenue
6.7%
Capex IntensityCapex / Revenue
8.1%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBT
CBT
VIRT
VIRT
Q1 26
Q4 25
$126.0M
$518.4M
Q3 25
$219.0M
$-68.7M
Q2 25
$249.0M
$62.8M
Q1 25
$73.0M
$15.0M
Q4 24
$124.0M
$599.0M
Q3 24
$204.0M
$112.1M
Q2 24
$207.0M
$490.8M
Free Cash Flow
CBT
CBT
VIRT
VIRT
Q1 26
Q4 25
$57.0M
$495.6M
Q3 25
$155.0M
$-76.7M
Q2 25
$188.0M
$57.6M
Q1 25
$1.0M
$9.2M
Q4 24
$47.0M
$586.6M
Q3 24
$112.0M
$106.2M
Q2 24
$155.0M
$486.9M
FCF Margin
CBT
CBT
VIRT
VIRT
Q1 26
Q4 25
6.7%
51.1%
Q3 25
17.2%
-9.3%
Q2 25
20.4%
5.8%
Q1 25
0.1%
1.1%
Q4 24
4.9%
70.3%
Q3 24
11.2%
15.0%
Q2 24
15.3%
70.3%
Capex Intensity
CBT
CBT
VIRT
VIRT
Q1 26
Q4 25
8.1%
2.4%
Q3 25
7.1%
1.0%
Q2 25
6.6%
0.5%
Q1 25
7.7%
0.7%
Q4 24
8.1%
1.5%
Q3 24
9.2%
0.8%
Q2 24
5.1%
0.6%
Cash Conversion
CBT
CBT
VIRT
VIRT
Q1 26
Q4 25
1.73×
3.71×
Q3 25
5.09×
-0.89×
Q2 25
2.47×
0.42×
Q1 25
0.78×
0.15×
Q4 24
1.33×
6.37×
Q3 24
1.49×
1.87×
Q2 24
1.90×
7.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

VIRT
VIRT

Trading income, net$789.1M72%
Commissions, net and technology services$186.6M17%
Other$119.6M11%

Related Comparisons